NCT05950399View on ClinicalTrials.gov

Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 29, 2015

Primary Completion Date

March 19, 2024

Study Completion Date

March 19, 2024

Conditions
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Interventions
PROCEDURE

Echocardiography

Undergo resting echocardiography

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Stress Echocardiography

Undergo stress echocardiography

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05950399 - Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk | Biotech Hunter | Biotech Hunter